PHAR · NASDAQ
Pharming Group (PHAR) Stock Price & Fundamentals
Pharming Group (PHAR) closed at $403.78 on Oct 9, 2026, up 0.17% from the previous close of $403.09.
Share price, past year
1Y +5.08%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $403.78 |
| Sep 30, 2026 | $404.43 |
| Aug 31, 2026 | $416.79 |
| Jul 31, 2026 | $421.07 |
| Jun 30, 2026 | $410.93 |
| May 29, 2026 | $420.40 |
| Apr 30, 2026 | $398.89 |
| Mar 31, 2026 | $408.78 |
| Feb 27, 2026 | $405.48 |
| Jan 30, 2026 | $397.29 |
| Dec 31, 2025 | $401.87 |
| Nov 28, 2025 | $390.70 |
| Oct 31, 2025 | $404.77 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 701.7M
- Dividend yield
- —
- 52-week range
- $375.78 – $434.76
Market cap, P/E and dividend yield aren't shown for Pharming Group yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US.
Financials
Pharming Group reported revenue of $376.13M for fiscal 2025, up 26.56% from fiscal 2024.
Pharming Group earned net income of $2.85M in fiscal 2025, a net margin of 0.8%.
Fiscal 2025 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $376.13M | +26.6% | $2.85M | 0.8% | $0.004 | $53.96M |
| FY2024ended Dec 31, 2024 | $297.20M | +21.2% | −$11.84M | −4.0% | −$0.018 | −$2.59M |
| FY2023ended Dec 31, 2023 | $245.32M | +19.3% | −$10.55M | −4.3% | −$0.016 | −$18.74M |
| FY2022ended Dec 31, 2022 | $205.62M | +3.4% | — | — | $0.019 | $21.08M |
| FY2021ended Dec 31, 2021 | $198.87M | −6.3% | — | — | $0.023 | $27.10M |
| FY2020ended Dec 31, 2020 | $212.17M | +12.0% | — | — | $0.055 | $78.97M |
| FY2019ended Dec 31, 2019 | $189.39M | — | — | — | $0.06 | $71.50M |
Company profile
- Name
- Pharming Group N.V.
- Ticker
- PHAR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Darwinweg 24, Leiden, P7 2333 CR
- Incorporated in
- P7
- Fiscal year ends
- December
- SEC CIK
- 0001828316
Recent SEC filings
- Apr 13, 2026
- Apr 2, 2026
- Apr 3, 2025
- Apr 4, 2024
- Apr 5, 2023
- Apr 6, 2022
- Apr 7, 2021
Related stocks
Pharming Group's industry, as the SEC classifies it, is Pharmaceutical Preparations. The companies in it closest to Pharming Group in revenue are Arcutis Biotherapeutics, Sinovac Biotech and MannKind.
Frequently asked questions
What is Pharming Group's stock price?
Pharming Group (PHAR) closed at $403.78 on Oct 9, 2026, up 0.17% from the previous close of $403.09.
How much revenue does Pharming Group make?
Pharming Group reported revenue of $376.13M for fiscal 2025, up 26.56% from fiscal 2024.
Sources and methodology
Fundamentals come from Pharming Group N.V.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures